Characterization of Ty21a immunostimulatory effects in the mouse bladder

Area of Science:

• Immunology
• Oncology
• Microbiology

Background:

• Intravesical Salmonella Ty21a shows promise for bladder cancer treatment by recruiting immune cells, particularly CD8+ T-cells.
• The precise mechanisms of its efficacy and the influence of bacterial formulation remain incompletely understood.

Purpose of the Study:

• To investigate the mechanisms of Salmonella Ty21a-mediated bladder cancer immunotherapy.
• To compare the efficacy of freshly harvested (Ty21aFR) versus lyophilized (Ty21aLYO) Salmonella Ty21a formulations.
• To elucidate the role of bacterial components and host immune pathways in treatment response.

Main Methods:

• Intravesical administration of Ty21aFR and Ty21aLYO in the MB49 bladder cancer mouse model.
• Analysis of immune cell infiltration, vascular permeability, and chemokine expression.
• Assessment of T-cell and myeloid cell recruitment.
• Evaluation of the role of Toll-like receptor 4 (TLR4) and MyD88 signaling pathways using knockout mice.

Main Results:

• Both Ty21aFR and Ty21aLYO increased vascular permeability, but only Ty21aFR significantly enhanced immune cell recruitment and tumor regression.
• Ty21aFR treatment led to increased levels of C5a, CXCL2, and CXCL5, with myeloid cells playing an indirect role in T-cell recruitment.
• CD8+ T-cell infiltration was dependent on TLR4 and MyD88, while myeloid cell recruitment involved TLR4-independent pathways.

Conclusions:

• Bacterial formulation significantly impacts the immunostimulatory effects of Salmonella Ty21a in bladder cancer.
• Freshly harvested Ty21aFR demonstrates superior efficacy due to enhanced immune cell recruitment, partly mediated by TLR4 signaling.
• These findings provide crucial insights into optimizing Salmonella-based immunotherapies for bladder cancer.